Pharma News in Global Health and Sustainability
A roundup of developments in global health and sustainability from the bio/pharmaceutical industry, its suppliers, and other public and private organizations.
What Happened to Outsourcing in Asia?
The industry may not be ready for India and China as regulatory issues emerge.
Pfizer, Merck, Sanofi, and AstraZeneca Facing the Generic-Drug Squeeze
Pfizer, Merck, Sanofi, and AstraZeneca are among the companies reporting revenue declines from generic-drug incursion. A look at what the companies are doing to stimulate growth.
Gauging Investment in High-Potency Manufacturing
Contract service providers expand capabilities in API and finished product manufacturing to meet demand for high-potency drugs
